Hepatotoxicity related to citalopram;Hepatitis tóxica por escitalopram

Medicina Clinica

Volumn 131, Issue 20, 2008, Pages 798-

  del Val Antoñana, Adolfo ^a   Ortiz Polo, Inmaculada ^a   Roselló Sastre, Esther ^b   Moreno Osset, Eduardo ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ESCITALOPRAM; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ASTHENIA; CASE REPORT; DEPRESSION; FEMALE; FEVER; HUMAN; JAUNDICE; LETTER; RASH; TOXIC HEPATITIS;

CITALOPRAM; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 63549089854     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/S0025-7753(08)75510-6     Document Type: Letter

References (8)

1. Mourilhe P., and Stokes P.E. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depressión. Drug Saf 18 (1998) 57-82
2. Carvajal G.P., García D., Sánchez S.A., Velasco M.A., Rueda D., and Lucena M.I. Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry 63 (2002) 135-137
3. Danan G., and Benichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46 (1993) 1323-1330
4. Cai Q., Benson M.A., Talbot T.J., Devadas J., Swanson H.J., Olson J.L., et al. Acute hepatitis due to fluoxetine therapy. Mayo Clin Proc 74 (1999) 692-694
5. Cosme A., Barrio J., Lobo C., Gil I., Castiella A., and Arenas J.I. Acute cholestasis by fluoxetine. Am J Gastroenterol 91 (1996) 2449-2450
6. Odeh M., Misselevech I., Boss J.H., and Oliven A. Severe hepatotoxicity with jaundice associated with paroxetine. Am J Gastroenterol 96 (2001) 2494-2496
7. Milkiewicz P., Chilton A.P., Hubscher S.G., and Elias E. Antidepressant induced cholestasis hepatocellular redistribution of multidrug resistant protein (MRP2). Gut 52 (2003) 300-303
8. López-Torres E., Lucena M.I., Seoane J., Verge C., and Andrade R.J. Hepatotoxicity related to citalopram. Am J Psychiatry 161 (2004) 923-924